Covera-HS, a new timed-release verapamil designed for BEDTIME dosing
April 1996
Searle will soon launch Covera-HS, a new timed-release verapamil designed for BEDTIME dosing.
It's approved for either hypertension or angina.
The idea is to provide peak effects in the MORNING when blood pressure and heart rate tend to be highest...and patients are most vulnerable to chest pain or a heart attack.
Get concise advice on drug therapy, plus unlimited access to CE
Pharmacist's Letter membership benefits include:
- 12 issues every year — what you need to know and do, right now
- Quick, practical reference charts and tools
- Comprehensive CE library to meet license renewal and state requirements
- Multiple course formats including live webinars, podcasts, and CE-in-the-Letter to match your learning style
- Plus much more!
Choose the right tier for your needs today.
Already a subscriber? Log in
Volume pricing available. Get a quote